1. Home
  2. NISN vs CANF Comparison

NISN vs CANF Comparison

Compare NISN & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NiSun International Enterprise Development Group Co. Ltd.

NISN

NiSun International Enterprise Development Group Co. Ltd.

HOLD

Current Price

$0.98

Market Cap

5.0M

Sector

Industrials

ML Signal

HOLD

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

HOLD

Current Price

$4.03

Market Cap

5.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NISN
CANF
Founded
2005
1994
Country
China
Israel
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
5.4M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
NISN
CANF
Price
$0.98
$4.03
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9,750.00
AVG Volume (30 Days)
33.0K
88.0K
Earning Date
04-28-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$238,745,633.00
$560,000.00
Revenue This Year
N/A
$461.72
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.91
$3.36
52 Week High
$9.33
$46.60

Technical Indicators

Market Signals
Indicator
NISN
CANF
Relative Strength Index (RSI) 22.30 64.75
Support Level $1.05 $3.87
Resistance Level $1.17 $4.55
Average True Range (ATR) 0.10 0.29
MACD 0.07 -0.12
Stochastic Oscillator 2.94 23.87

Price Performance

Historical Comparison
NISN
CANF

About NISN NiSun International Enterprise Development Group Co. Ltd.

NiSun International Enterprise Development Group Co Ltd is a provider of supply chain solutions and integrated financial services. Nisun is dedicated to providing professional supply chain solutions to Chinese and foreign enterprises and financial institutions. Through its subsidiaries, it is engaged in delivering supply chain solutions, and supply chain trading services to its customers across different industries. The company also provides financial solutions to small and mid-sized enterprises within the supply chain ecosystem. Using its fintech platforms, it provides various financing options, including supply chain financing, trade financing, and receivables financing. Geographically, its operations are predominantly focused on markets within the People's Republic of China.

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Share on Social Networks: